Suppr超能文献

一例患有古德综合征患者的重症新型冠状病毒肺炎病例。

A Case of Severe COVID-19 in a Patient with Good's Syndrome.

作者信息

Duarte Maria, Faria Luciana, Patronillo Catarina, da Costa Fernandes Sónia, Seara Vera

机构信息

Internal Medicine Department, Centro Hospitalar Póvoa de Varzim - Vila do Conde, Portugal.

出版信息

Eur J Case Rep Intern Med. 2021 Oct 29;8(10):002976. doi: 10.12890/2021_002976. eCollection 2021.

Abstract

UNLABELLED

Good's syndrome is a rare adult-onset combined immunodeficiency. The association of hypogammaglobulinaemia with a history of recurrent infectious or autoimmune manifestations in a middle-aged patient with evidence of a mediastinal mass should lead to the clinical suspicion of Good's syndrome. The mortality rate associated with infectious complications is high. Thus, although it is rare, the disease should be diagnosed early so that proper treatment can be started. Thymectomy and immunoglobulin replacement are the main therapeutic strategies. We describe the case of a patient with a history of thymoma and recurrent respiratory infections, with a late diagnosis of Good's syndrome in the context of severe organizing pneumonia secondary to COVID-19.

LEARNING POINTS

Infection is the leading cause of mortality in patients with Good's syndrome.Early recognition of this rare disease and substitutive therapy with immunoglobulin may have an important impact on prognosis.Due to its rarity, data on Good's syndrome are scarce and its association with severe COVID-19 onset is still unclear.To the best of our knowledge, this is the fifth case report of COVID-19 in a patient with Good's syndrome, the third with a favourable outcome.

摘要

未标注

古德综合征是一种罕见的成人起病的联合免疫缺陷病。在一名有纵隔肿块证据的中年患者中,低丙种球蛋白血症与反复感染或自身免疫表现病史相关,应引起对古德综合征的临床怀疑。与感染并发症相关的死亡率很高。因此,尽管该病罕见,但应尽早诊断以便开始适当治疗。胸腺切除术和免疫球蛋白替代是主要的治疗策略。我们描述了一名有胸腺瘤病史和反复呼吸道感染的患者的病例,该患者在继发于新型冠状病毒肺炎的严重机化性肺炎背景下被晚期诊断为古德综合征。

学习要点

感染是古德综合征患者死亡的主要原因。早期识别这种罕见疾病并使用免疫球蛋白进行替代治疗可能对预后有重要影响。由于其罕见性,关于古德综合征的数据稀少,其与新型冠状病毒肺炎严重发病的关联仍不清楚。据我们所知,这是第五例关于古德综合征患者感染新型冠状病毒肺炎的病例报告,第三例有良好结局。

相似文献

1
A Case of Severe COVID-19 in a Patient with Good's Syndrome.
Eur J Case Rep Intern Med. 2021 Oct 29;8(10):002976. doi: 10.12890/2021_002976. eCollection 2021.
2
Persistent Fever and Cough in a Patient With Good's Syndrome: A Case Report.
Cureus. 2022 May 14;14(5):e24996. doi: 10.7759/cureus.24996. eCollection 2022 May.
3
Good's syndrome with clinical manifestation after thymectomy: A case report.
Respir Med Case Rep. 2018 Apr 27;24:89-91. doi: 10.1016/j.rmcr.2018.04.014. eCollection 2018.
4
A Case of Good's Syndrome Presenting with Pulmonary Tuberculosis.
Indian J Chest Dis Allied Sci. 2015 Oct-Dec;57(4):247-50.
5
Beware of the Patient with Thymectomy: Good's Syndrome in a Patient Presenting with Diarrhea.
ACG Case Rep J. 2013 Oct 8;1(1):33-5. doi: 10.14309/crj.2013.13. eCollection 2013 Oct.
7
A Bad Case of Good's Syndrome.
Infect Dis Ther. 2014 Dec;3(2):333-7. doi: 10.1007/s40121-014-0045-7. Epub 2014 Oct 7.
8
Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).
Clin Exp Immunol. 2019 Jan;195(1):132-138. doi: 10.1111/cei.13216. Epub 2018 Oct 21.
9
Good's syndrome with increasing γδ T-lymphocyte subpopulation: A case report.
Vojnosanit Pregl. 2015 Nov;72(11):1039-43. doi: 10.2298/vsp140609102t.
10
Goods syndrome combined with bronchiectasis: A case report and literature review.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Mar 28;46(3):328-332. doi: 10.11817/j.issn.1672-7347.2021.190777.

引用本文的文献

1
Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review.
Clin Case Rep. 2024 May 27;12(6):e8962. doi: 10.1002/ccr3.8962. eCollection 2024 Jun.
3
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.
Immunol Rev. 2024 Mar;322(1):98-112. doi: 10.1111/imr.13304. Epub 2024 Jan 9.
4
Good's syndrome and COVID-19: case report and literature review.
Mediastinum. 2022 Sep 9;7:5. doi: 10.21037/med-22-12. eCollection 2023.
5
COVID-19 and Inborn Errors of Immunity.
Physiology (Bethesda). 2022 Nov 1;37(6):0. doi: 10.1152/physiol.00016.2022. Epub 2022 Aug 9.
6
[Patient with Good's syndrome and COVID-19. Report of a clinical case].
Rev Med Inst Mex Seguro Soc. 2022 Jul 4;60(4):474-479.

本文引用的文献

1
Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.
Clin Immunol. 2022 Feb;235:108789. doi: 10.1016/j.clim.2021.108789. Epub 2021 Jun 29.
2
[COVID-19 in adults with antibody deficiencies].
Medicina (B Aires). 2021;81(3):478-481.
3
When the Good Syndrome Goes Bad: A Systematic Literature Review.
Front Immunol. 2021 May 25;12:679556. doi: 10.3389/fimmu.2021.679556. eCollection 2021.
4
Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin.
Immunol Lett. 2021 Mar;231:11-17. doi: 10.1016/j.imlet.2020.12.010. Epub 2021 Jan 5.
5
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy.
J Clin Immunol. 2021 Feb;41(2):356-361. doi: 10.1007/s10875-020-00904-5. Epub 2020 Nov 20.
6
Good's syndrome, a rare form of acquired immunodeficiency associated with thymomas.
Clin Pract. 2019 Jun 5;9(2):1112. doi: 10.4081/cp.2019.1112. eCollection 2019 May 6.
7
Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective.
Clin Immunol. 2016 Oct;171:12-17. doi: 10.1016/j.clim.2016.07.025. Epub 2016 Aug 4.
8
Humoral Immunity in Bronchiectasis: Finding Good's Syndrome.
Case Rep Pulmonol. 2015;2015:531731. doi: 10.1155/2015/531731. Epub 2015 Dec 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验